MaltSci 麦伴科研

Appearance

Popular Reports / Cancer Research

This report is written by MaltSci based on the latest literature and research findings

What is the role of exosomes in cancer communication? ​

Abstract ​

Exosomes are small extracellular vesicles that have emerged as critical mediators of intercellular communication in cancer. Their ability to transfer bioactive molecules, including proteins, lipids, and nucleic acids, plays a significant role in influencing tumor behavior and the tumor microenvironment. This review explores the biogenesis and composition of exosomes, detailing the mechanisms involved in their formation and the molecular cargo they carry. We discuss how exosomes facilitate tumor growth and metastasis by modulating signaling pathways and immune responses, highlighting their dual role as facilitators of tumor progression and potential therapeutic targets. The clinical implications of exosomes are also examined, focusing on their potential as biomarkers for cancer diagnosis and therapeutic agents for targeted delivery. Furthermore, we identify key research gaps and challenges in the field, particularly regarding the engineering of exosomes for clinical applications. Understanding the multifaceted roles of exosomes in cancer communication offers promising avenues for innovative diagnostic and therapeutic strategies, contributing to the ongoing efforts to enhance cancer management and improve patient outcomes.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Exosome Biogenesis and Composition
    • 2.1 Mechanisms of Exosome Formation
    • 2.2 Molecular Composition of Exosomes
  • 3 Exosomes in Tumor Microenvironment
    • 3.1 Role of Exosomes in Tumor Growth
    • 3.2 Exosome Influence on Tumor Metastasis
  • 4 Exosome-mediated Communication in Cancer
    • 4.1 Signaling Pathways Modulated by Exosomes
    • 4.2 Exosomes and Immune Evasion
  • 5 Clinical Implications of Exosomes in Cancer
    • 5.1 Exosomes as Biomarkers for Cancer Diagnosis
    • 5.2 Therapeutic Potential of Targeting Exosomes
  • 6 Future Directions and Challenges
    • 6.1 Research Gaps in Exosome Biology
    • 6.2 Overcoming Challenges in Exosome-based Therapies
  • 7 Summary

1 Introduction ​

Exosomes are small extracellular vesicles, typically ranging from 30 to 150 nm in diameter, that have emerged as critical mediators of intercellular communication, particularly in the context of cancer. These vesicles are secreted by various cell types and are involved in the transfer of bioactive molecules, including proteins, lipids, and nucleic acids, between cells. The significance of exosomes in cancer communication is underscored by their ability to influence the tumor microenvironment, thereby affecting processes such as tumor growth, metastasis, and immune evasion [1][2]. Recent advancements in our understanding of exosome biology have illuminated their roles in modulating cellular interactions and signaling pathways, positioning them as both potential biomarkers and therapeutic targets in oncology [3][4].

The role of exosomes in cancer is multifaceted, encompassing various aspects of tumor biology. Exosomes are not only involved in the dissemination of oncogenic signals but also play a pivotal role in shaping the tumor microenvironment by facilitating communication between tumor cells and stromal or immune cells [5][6]. This communication can promote tumorigenesis, enhance metastatic potential, and contribute to treatment resistance [4][7]. As such, understanding the mechanisms underlying exosome biogenesis, composition, and function is essential for deciphering their contributions to cancer progression and therapy [1][5].

The current state of research on exosomes in cancer has revealed several key areas of focus. First, the biogenesis and composition of exosomes are critical to their function in intercellular communication. Studies have elucidated the mechanisms of exosome formation and the specific molecular cargo they carry, which can include regulatory RNAs such as microRNAs (miRNAs) that influence recipient cell behavior [2][8]. Second, the role of exosomes in the tumor microenvironment has been extensively investigated, highlighting their impact on tumor growth and metastasis [4][5]. Third, exosome-mediated communication in cancer has been linked to various signaling pathways that modulate immune responses and tumor cell interactions [2][9].

This review is organized into several sections to systematically explore the complex roles of exosomes in cancer. The first section will address exosome biogenesis and composition, detailing the mechanisms of exosome formation and the molecular constituents involved. The second section will focus on the role of exosomes within the tumor microenvironment, examining how they influence tumor growth and metastasis. Following this, we will delve into the mechanisms of exosome-mediated communication in cancer, highlighting the signaling pathways that are modulated by exosomal cargo and the implications for immune evasion. The clinical implications of exosomes will be discussed next, emphasizing their potential as biomarkers for cancer diagnosis and therapeutic targets. Finally, we will outline future directions and challenges in the field, identifying research gaps and potential strategies to overcome obstacles in exosome-based therapies.

In summary, exosomes represent a dynamic and versatile mode of intercellular communication in cancer, with significant implications for understanding tumor biology and developing innovative diagnostic and therapeutic strategies. By elucidating the multifaceted roles of exosomes, this review aims to contribute to the ongoing efforts to harness their potential in cancer management and improve patient outcomes.

2 Exosome Biogenesis and Composition ​

2.1 Mechanisms of Exosome Formation ​

Exosomes are small extracellular vesicles ranging from 30 to 150 nm in diameter that play a pivotal role in intercellular communication, particularly in the context of cancer. They are released by various cell types, including tumor cells, and contain a diverse array of biomolecules, such as proteins, lipids, and nucleic acids (including microRNAs). The composition of exosomes reflects the physiological state of their parent cells, thus providing insight into the tumor microenvironment and the overall health of the cells involved [8].

The biogenesis of exosomes involves a complex process that begins with the inward budding of the plasma membrane, leading to the formation of early endosomes. These early endosomes can then mature into multivesicular bodies (MVBs), which subsequently fuse with the plasma membrane to release exosomes into the extracellular space [5]. This process is regulated by various molecular pathways, including those associated with the endosomal sorting complex required for transport (ESCRT) machinery, which is crucial for the sorting of cargo into exosomes [5].

Exosomes facilitate cancer communication through several mechanisms. They can transfer bioactive molecules between tumor cells and their microenvironment, influencing processes such as tumor proliferation, metastasis, and immune evasion [1]. For instance, tumor-derived exosomes (TDEs) have been shown to enhance tumor cell proliferation and promote resistance to therapies by delivering specific regulatory RNAs, such as microRNAs, that modulate gene expression in recipient cells [3]. Additionally, exosomes can affect stromal cells, thereby altering the tumor microenvironment to favor cancer progression [1].

Moreover, exosomes are involved in the modulation of immune responses within the tumor microenvironment. They can carry immunosuppressive molecules that inhibit the activity of immune cells, allowing cancer cells to escape immune surveillance [10]. The exchange of exosomes between cancer cells and immune cells exemplifies the intricate communication network that exists in tumors, highlighting the dual role of exosomes as both facilitators of tumor progression and potential targets for therapeutic intervention [1].

In summary, exosomes are integral to cancer communication, serving as vehicles for the transfer of molecular signals that influence tumor behavior and the surrounding microenvironment. Their biogenesis involves complex cellular processes, and their diverse composition allows them to exert significant effects on cancer progression and immune modulation. Understanding these mechanisms offers promising avenues for developing novel diagnostic and therapeutic strategies targeting exosome-mediated communication in cancer [1][2][6].

2.2 Molecular Composition of Exosomes ​

Exosomes, which are small extracellular vesicles ranging from 40 to 100 nm in diameter, play a pivotal role in intercellular communication, particularly within the context of cancer. These vesicles are released by various cell types, including tumor cells, and serve as carriers of bioactive molecules such as proteins, lipids, nucleic acids, and other metabolites. The molecular composition of exosomes can vary significantly based on their cellular origin and the physiological state of the cells from which they are derived.

In the realm of cancer, exosomes contribute to the tumor microenvironment by facilitating communication between tumor cells and surrounding stromal cells, immune cells, and other components of the microenvironment. They achieve this by transferring regulatory RNAs, including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), which can modulate the behavior of recipient cells and influence tumor progression, metastasis, and therapy resistance [2].

The biogenesis of exosomes involves the inward budding of the endosomal membrane, leading to the formation of multivesicular bodies (MVBs). These MVBs can either fuse with lysosomes for degradation or with the plasma membrane to release exosomes into the extracellular space [5]. The composition of exosomes reflects the physiological state of the parent cell and can include a variety of molecular components such as proteins involved in signaling pathways, RNA species that can alter gene expression in recipient cells, and lipids that contribute to the structural integrity of the vesicles [1].

Exosomes have been shown to play multifaceted roles in cancer communication. For instance, they can enhance tumor proliferation and metastasis by delivering oncogenic signals to adjacent cells, thus creating a supportive microenvironment for tumor growth [1]. Additionally, exosomes can facilitate immune evasion by transferring immunosuppressive factors that inhibit the activity of immune cells, thereby allowing tumor cells to escape immune surveillance [4].

Moreover, the unique molecular cargo of exosomes makes them promising candidates for diagnostic and therapeutic applications. They can serve as biomarkers for cancer diagnosis, as their content can reflect the molecular profile of the tumor [9]. Furthermore, engineered exosomes are being explored as vehicles for targeted drug delivery, potentially enhancing the efficacy of cancer therapies while minimizing side effects [6].

In summary, exosomes are critical mediators of intercellular communication in cancer, influencing tumor biology through their complex molecular composition and facilitating various processes that contribute to cancer progression and therapy resistance. Their role as communicators in the tumor microenvironment underscores their potential as targets for novel therapeutic strategies and diagnostic tools.

3 Exosomes in Tumor Microenvironment ​

3.1 Role of Exosomes in Tumor Growth ​

Exosomes, which are extracellular vesicles ranging from 40 to 100 nm in diameter, play a crucial role in intercellular communication within the tumor microenvironment. They are involved in mediating the exchange of various bioactive molecules, including proteins, lipids, nucleic acids, and metabolites, between tumor cells and their surrounding environment. This communication is essential for the modulation of tumor behavior and the progression of cancer.

In the context of cancer, exosomes facilitate tumor growth and metastasis by transferring regulatory RNAs, such as microRNAs (miRNAs), which can influence the behavior of recipient cells. For instance, cancer-derived exosomes have been shown to enhance communication within the tumor microenvironment, promoting tumor proliferation, metastasis, and therapy resistance by activating oncogenic pathways like MAPK and PI3K-Akt [2]. This underscores the dual nature of exosomes, which can either promote or inhibit cancer progression depending on their cellular origin and molecular cargo.

Moreover, exosomes contribute to the establishment of a pro-tumorigenic microenvironment by influencing the behavior of immune cells and stromal cells. Tumor cells release exosomes that can modulate the immune response, allowing tumors to evade immune surveillance and create a supportive niche for growth and metastasis [9]. For example, tumor exosomes can convey signals that suppress T cell activity and skew the polarization of macrophages towards a phenotype that supports tumor progression [11].

Additionally, exosomes have been identified as potential biomarkers for cancer diagnosis due to their stability and presence in body fluids, making them accessible for non-invasive testing [4]. Their ability to carry molecular signatures reflective of the tumor’s state positions them as promising candidates for both diagnostic and therapeutic applications.

The therapeutic potential of exosomes is also significant. By engineering exosomes, researchers aim to create targeted drug delivery systems that can minimize the side effects associated with conventional treatments like chemotherapy and radiation. Exosomes can be modified to enhance their targeting capabilities, allowing for more effective delivery of therapeutic agents directly to tumor cells [6].

In summary, exosomes serve as vital communicators within the tumor microenvironment, influencing tumor growth, metastasis, and therapeutic resistance. Their role as mediators of intercellular communication positions them as both a target for therapeutic intervention and a tool for diagnostic advancements in cancer treatment [2][7][9].

3.2 Exosome Influence on Tumor Metastasis ​

Exosomes, which are small extracellular vesicles ranging from 30 to 150 nm in diameter, play a pivotal role in cancer communication and significantly influence the tumor microenvironment and metastasis. They facilitate intercellular communication by transferring a diverse array of biomolecules, including proteins, lipids, nucleic acids, and other metabolites, thereby modulating various biological processes within and between cells.

In the context of cancer, exosomes are released by tumor cells and other cells within the tumor microenvironment, such as adipocytes and fibroblasts. These vesicles carry regulatory RNAs, including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), which can promote or inhibit cancer progression through signaling pathways like MAPK and PI3K-Akt [2]. By influencing the behavior of recipient cells, exosomes contribute to tumor proliferation, metastasis, and therapy resistance, thereby enhancing communication within the tumor microenvironment [2].

Exosomes are implicated in several critical processes related to metastasis. They aid in the epithelial-to-mesenchymal transition (EMT), a process essential for cancer cell migration and invasion, and facilitate the formation of pre-metastatic niches in distant organs [12]. This communication is crucial as it allows cancer cells to modify their microenvironment, enabling them to escape immune surveillance and promoting angiogenesis, which is vital for tumor growth and metastasis [13].

Furthermore, exosomes protect tumor cells from the cytotoxic effects of chemotherapy and can transfer chemoresistance properties to nearby cells, thereby complicating treatment strategies [13]. They also play a role in the activation of cancer stem cells (CSCs), which are integral to tumor recurrence and metastasis, as these cells secrete exosomes that modulate the tumor microenvironment [14].

The lipid composition of exosomes is particularly noteworthy, as it is often found to be higher than that of other cargos. This lipid content can influence signaling pathways, immunomodulation, and energy production, contributing to cancer cell survival and progression [15]. Thus, exosomes not only serve as carriers of molecular information but also actively participate in the regulatory networks that govern tumor behavior.

In summary, exosomes are crucial mediators of communication within the tumor microenvironment, influencing cancer progression, metastasis, and treatment responses. Their ability to shuttle various biomolecules allows them to orchestrate complex interactions between tumor cells and their surrounding environment, making them significant players in cancer biology and potential targets for therapeutic intervention [1][4][16].

4 Exosome-mediated Communication in Cancer ​

4.1 Signaling Pathways Modulated by Exosomes ​

Exosomes are small extracellular vesicles that play a pivotal role in intercellular communication, particularly within the context of cancer. These vesicles, typically ranging from 30 to 150 nm in diameter, are secreted by various cell types, including tumor cells, and are involved in transferring a diverse array of biomolecules, such as proteins, lipids, nucleic acids, and metabolites. The cargo carried by exosomes can significantly influence the behavior of recipient cells, thereby modulating various signaling pathways that are crucial for cancer progression.

In cancer, exosomes contribute to several key processes, including tumor proliferation, metastasis, and the development of therapy resistance. Tumor-derived exosomes (TDEs) have been shown to alter the tumor microenvironment by carrying regulatory RNAs, such as microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), which can affect signaling pathways like MAPK and PI3K-Akt. These pathways are essential for cellular processes such as growth, survival, and apoptosis, thus playing a critical role in cancer cell activation and expansion [2].

Exosomes facilitate communication between tumor cells and their surrounding stroma, which is essential for the establishment of a supportive tumor microenvironment. They can enhance stromal cell reprogramming, promote immune evasion, and modulate extracellular matrix formation, thereby fostering an environment conducive to tumor growth and metastasis [1]. Furthermore, exosomes can also impart drug resistance to cancer cells by transferring proteins and RNAs that confer survival advantages in the presence of therapeutic agents [1].

The mechanisms through which exosomes mediate these effects are multifaceted. For instance, exosomes derived from cancer cells can transfer oncogenic factors to neighboring cells, influencing their behavior and promoting tumorigenesis. They can also engage in immune modulation by altering the activity of immune cells, thereby enabling tumors to evade immune surveillance [5]. In addition, exosomes can serve as vehicles for delivering therapeutic agents, enhancing targeted treatment strategies while minimizing off-target effects [6].

Research has indicated that the interaction between exosomes and recipient cells can lead to the activation of oncogenic signaling pathways, which is critical for the progression of malignancies. The study of exosomal cargo and its impact on signaling pathways is thus a vital area of research that may yield novel diagnostic and therapeutic strategies for cancer [1].

In summary, exosomes play a crucial role in cancer communication by mediating the transfer of bioactive molecules that influence signaling pathways associated with tumor growth, metastasis, and treatment resistance. Their ability to modulate the tumor microenvironment and interact with various cellular components highlights their potential as targets for innovative cancer therapies and diagnostic tools.

4.2 Exosomes and Immune Evasion ​

Exosomes, small extracellular vesicles ranging from 30 to 150 nm, play a crucial role in cancer communication by facilitating intercellular communication and influencing the tumor microenvironment (TME). They are secreted by various cell types, including tumor cells, and contain a diverse array of molecular constituents such as proteins, lipids, nucleic acids, and non-coding RNAs, which can modulate the behavior of recipient cells.

In the context of cancer, exosomes are pivotal in mediating communication between tumor cells and immune cells, significantly impacting immune evasion. Tumor-derived exosomes (TDEs) have been shown to carry immunosuppressive proteins, cytokines, and non-coding RNAs that reprogram immune cell functions, thereby establishing an immunosuppressive TME. For instance, TDEs can induce apoptosis in CD8+ T cells, promote the generation of regulatory T cells (Tregs), suppress natural killer (NK) cell cytotoxicity, inhibit monocyte maturation, and enhance the suppressive function of myeloid-derived suppressor cells (MDSCs) [17][18].

Moreover, exosomes can alter the immune landscape by influencing major immune cell subsets, including T cells, B cells, NK cells, dendritic cells, and macrophages. This modulation can lead to immune evasion and tumor progression, as TDEs effectively disrupt immune surveillance mechanisms [18]. The immunosuppressive properties of exosomes are critical for tumor cells to escape immune detection and continue proliferating [19].

Exosomes also contribute to the formation of a pre-metastatic niche by transferring pro-tumorigenic signals to distant sites, which aids in the metastasis of cancer cells [20]. They are involved in processes such as angiogenesis, epithelial-mesenchymal transition (EMT), and the activation of cancer-associated fibroblasts, all of which are essential for tumor growth and spread [20].

Furthermore, the content of exosomes can vary significantly between cancer patients and healthy individuals, indicating their potential as biomarkers for cancer diagnosis and prognosis [17]. The ability of exosomes to serve as vehicles for therapeutic delivery and their role as non-invasive biomarkers for cancer monitoring are also being explored, highlighting their multifaceted involvement in cancer biology [21].

In summary, exosomes are integral to cancer communication, particularly in facilitating immune evasion. By modulating immune responses and influencing the TME, exosomes enable tumor cells to escape immune surveillance, promote tumor progression, and create a supportive environment for metastasis. The ongoing research into exosome biology offers promising avenues for developing novel cancer immunotherapies and diagnostic tools.

5 Clinical Implications of Exosomes in Cancer ​

5.1 Exosomes as Biomarkers for Cancer Diagnosis ​

Exosomes, which are nanosized extracellular vesicles ranging from 30 to 160 nanometers, have emerged as critical mediators in intercellular communication, particularly in the context of cancer. They are secreted by various cell types, including tumor cells, and play a multifaceted role in the tumor microenvironment, influencing processes such as tumor initiation, growth, progression, metastasis, and drug resistance. The cargo carried by exosomes, which includes proteins, DNA, mRNA, and non-coding RNAs, enables them to shuttle bioactive molecules from one cell to another, leading to the reprogramming of recipient cells and the exchange of genetic information[4][22][23].

In cancer, exosomes facilitate communication not only among tumor cells but also between tumor cells and surrounding stromal and immune cells. This interaction can contribute to immune evasion, the formation of a supportive tumor niche, and the modulation of the tumor microenvironment, thereby enhancing tumor progression and metastasis[1][4]. For instance, tumor-derived exosomes can alter the behavior of nearby non-tumor cells, promoting a more favorable environment for tumor growth and dissemination[22][24].

Clinically, exosomes have garnered significant interest as potential biomarkers for cancer diagnosis and monitoring. Their ability to reflect the biological state of their parental cells makes them valuable for early detection, diagnosis, and therapeutic response assessment. Since exosomes are present in various biofluids such as blood, saliva, and urine, they can be utilized in non-invasive liquid biopsies[24][25]. Exosomal content, particularly tumor-specific RNA and proteins, has been implicated in tumorigenesis and treatment response, providing a promising avenue for the development of diagnostic and prognostic biomarkers[24][26].

Moreover, the unique characteristics of exosomes, including their stability and cell type specificity, enhance their potential as therapeutic targets. Research has indicated that exosomes can be engineered to deliver therapeutic agents directly to cancer cells, thereby improving treatment efficacy and reducing off-target effects[1][26]. Thus, the exploration of exosomes not only deepens the understanding of cancer biology but also opens new pathways for innovative diagnostic and therapeutic strategies in oncology.

5.2 Therapeutic Potential of Targeting Exosomes ​

Exosomes, which are small extracellular vesicles, play a crucial role in intercellular communication, particularly within the context of cancer. These vesicles are released by various cell types, including tumor cells, and carry a diverse array of bioactive molecules such as proteins, lipids, mRNAs, and non-coding RNAs. The involvement of exosomes in cancer communication is multifaceted, influencing tumor progression, metastasis, and therapeutic responses.

Exosomes facilitate communication between tumor cells and their microenvironment by transferring molecular signals that can alter the behavior of recipient cells. They have been implicated in promoting tumor growth and metastasis by transporting bioactive molecules from cancerous cells to other cells in both local and distant microenvironments. For instance, tumor-derived exosomes (TEXs) can modulate the immune response, enhance angiogenesis, and promote epithelial-mesenchymal transition, all of which are critical for cancer progression (Wang et al. 2024; Li et al. 2022) [1][27].

The therapeutic potential of targeting exosomes in cancer is significant. Exosomes can serve as biomarkers for early cancer detection and prognosis due to their ability to reflect the molecular characteristics of the tumor from which they originate. Their stability in body fluids makes them excellent candidates for non-invasive diagnostic tools (Zhou et al. 2021) [26]. Furthermore, exosomes can be engineered to enhance drug delivery, allowing for targeted therapy that minimizes side effects associated with traditional treatments like chemotherapy and radiation (Safaei et al. 2025; Mirgh et al. 2024) [6][28].

The dual nature of exosomes presents both challenges and opportunities in cancer therapy. On one hand, exosomes from cancer stem cells can nurture tumors and promote unwanted growth; on the other hand, exosomes derived from healthy cells, such as mesenchymal stem cells, can aid in tissue repair and regeneration (Safaei et al. 2025) [6]. This duality suggests that while exosomes can contribute to cancer progression, they also hold promise for therapeutic applications if properly harnessed.

In summary, exosomes play a pivotal role in cancer communication by mediating the transfer of information between tumor cells and their microenvironment. They are critical in influencing tumor behavior and present novel avenues for diagnosis and treatment. The engineering of exosomes for targeted drug delivery and the identification of exosomal biomarkers represent significant advancements in the fight against cancer, highlighting their potential as both a therapeutic target and a tool for precision oncology (Mirgh et al. 2024; Hsu et al. 2024) [9][28].

6 Future Directions and Challenges ​

6.1 Research Gaps in Exosome Biology ​

Exosomes play a pivotal role in cancer communication, acting as mediators of intercellular signaling and influencing various biological processes that are critical for tumor development and progression. These nanosized membrane-bound extracellular vesicles, typically ranging from 30 to 150 nm, are released by cancer cells and can carry a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids. Their involvement in cancer biology has garnered significant attention, particularly regarding their mechanisms of action and potential therapeutic applications.

Exosomes facilitate communication between cancer cells and their microenvironment, contributing to processes such as tumor growth, metastasis, angiogenesis, and immune evasion. They can transfer genetic material, including microRNAs, which can modulate the behavior of recipient cells and influence the tumor microenvironment (Zhang & Yu, 2019; Kim, 2022). For instance, exosomes derived from tumor cells can alter the phenotype of stromal cells, promoting a supportive environment for cancer progression (Wang et al., 2024). Moreover, exosomes have been implicated in the formation of pre-metastatic niches, where they prepare distant sites for tumor cell colonization (Pote & Gacche, 2025).

Despite the advances in understanding exosome biology, several research gaps remain. Firstly, the precise molecular mechanisms governing exosome biogenesis, secretion, and uptake by recipient cells are not fully elucidated. Identifying the regulatory pathways involved in these processes is crucial for harnessing exosomes in therapeutic contexts (McAndrews & Kalluri, 2019). Additionally, while exosomes are recognized as promising biomarkers for cancer diagnosis and prognosis, the specificity and sensitivity of these biomarkers in clinical settings require further validation (Zhou et al., 2021).

Another significant challenge is the engineering of exosomes for targeted therapy. Although exosomes can be modified to enhance their delivery of therapeutic agents, optimizing their targeting capabilities remains a complex task (Wu et al., 2024). Furthermore, the heterogeneity of exosomes derived from different cell types poses additional challenges in standardizing exosome-based therapies.

Future directions in exosome research should focus on the development of innovative exosome-based delivery systems that can selectively target cancer cells while minimizing off-target effects. Additionally, exploring the roles of exosomal non-coding RNAs in tumor immunity and their potential as therapeutic targets may provide new insights into cancer treatment strategies (Luongo et al., 2024). Addressing these gaps will be essential for advancing the clinical application of exosomes in oncology, potentially leading to more effective diagnostic and therapeutic approaches in cancer management.

6.2 Overcoming Challenges in Exosome-based Therapies ​

Exosomes are small extracellular vesicles that play a crucial role in intercellular communication, particularly in the context of cancer. They facilitate the transfer of bioactive molecules, including proteins, lipids, and nucleic acids, between tumor cells and their microenvironment, thereby influencing various biological processes such as tumor initiation, growth, progression, and metastasis. The role of exosomes in cancer communication is multifaceted, as they can convey signals that modify the behavior of recipient cells, enhance tumor proliferation, and contribute to therapy resistance [1][2][4].

Exosomes are involved in the modulation of the tumor microenvironment by transferring regulatory RNAs, such as microRNAs (miRNAs), which can alter the gene expression of recipient cells. This communication can lead to stromal cell reprogramming, immune evasion, and the establishment of a supportive niche for tumor growth [1][29]. Furthermore, tumor-derived exosomes can activate oncogenic signaling pathways, including MAPK and PI3K-Akt, thereby promoting cancer progression [2].

Despite the promising role of exosomes in cancer communication and therapy, several challenges remain in the development and application of exosome-based therapies. One significant challenge is the incomplete understanding of the biological functions and mechanisms of exosome biogenesis and release. The complexity of exosomal cargo and the variability in their composition depending on the cellular origin further complicate their therapeutic application [5][28].

Future directions in exosome research include the engineering of exosomes for targeted drug delivery and the development of exosome-based diagnostic and therapeutic platforms. This involves modifying exosomes to enhance their specificity and efficacy in delivering therapeutic agents directly to tumor cells, thereby minimizing off-target effects and improving treatment outcomes [6][29]. Moreover, ongoing research is focused on elucidating the molecular mechanisms underlying exosome-mediated communication in the tumor microenvironment, which could provide insights into new therapeutic strategies [26][30].

In conclusion, while exosomes hold great potential as mediators of intercellular communication in cancer and as therapeutic tools, addressing the challenges associated with their biological complexity and engineering is essential for the advancement of exosome-based therapies. Continued research in this field is crucial for unlocking the full potential of exosomes in cancer diagnostics and treatment [1][2].

7 Conclusion ​

Exosomes are integral players in the complex landscape of cancer communication, acting as mediators that facilitate intercellular signaling and influence tumor biology. The review highlights several key findings: first, exosomes are critical for the transfer of bioactive molecules that modulate tumor growth, metastasis, and immune evasion. Second, their composition reflects the physiological state of their parent cells, providing insights into the tumor microenvironment and potential therapeutic targets. Third, exosomes are emerging as promising biomarkers for cancer diagnosis and prognosis, given their stability and presence in various biofluids. Despite these advances, significant research gaps remain, particularly in understanding the molecular mechanisms governing exosome biogenesis, secretion, and uptake. Future research should focus on engineering exosomes for targeted therapies, enhancing their specificity and efficacy, and exploring their roles in tumor immunity. Addressing these challenges will be crucial for translating exosome biology into clinical applications, ultimately improving cancer management and patient outcomes.

References ​

  • [1] Yun Wang;Xiaojiang Li;Dalong Liu;Zhifeng Wang;Jichen Xia;Lijun Wang;Xudong Zhang. Research progress on the role of adipocyte exosomes in cancer progression.. Oncology research(IF=4.1). 2024. PMID:39308520. DOI: 10.32604/or.2024.043482.
  • [2] Nada Aakel;Rawdhah Mohammed;Assela Fathima;Rabia Kerzabi;Atiyeh Abdallah;Wisam Nabeel Ibrahim. Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment.. Cancer medicine(IF=3.1). 2025. PMID:40344389. DOI: 10.1002/cam4.70941.
  • [3] Zhao-Yu Shi;Xiao-Xia Yang;ChristinaYallen Malichewe;Ying-Shuang Li;Xiu-Li Guo. Exosomal microRNAs-mediated intercellular communication and exosome-based cancer treatment.. International journal of biological macromolecules(IF=8.5). 2020. PMID:32360962. DOI: 10.1016/j.ijbiomac.2020.04.228.
  • [4] Xu Zhang;Xiao Yuan;Hui Shi;Lijun Wu;Hui Qian;Wenrong Xu. Exosomes in cancer: small particle, big player.. Journal of hematology & oncology(IF=40.4). 2015. PMID:26156517. DOI: 10.1186/s13045-015-0181-x.
  • [5] Kathleen M McAndrews;Raghu Kalluri. Mechanisms associated with biogenesis of exosomes in cancer.. Molecular cancer(IF=33.9). 2019. PMID:30925917. DOI: 10.1186/s12943-019-0963-9.
  • [6] Mohsen Safaei;Seyedeh Somayeh Rajabi;Mahtab Tirgar;Najmeh Namdar;Mahsa Dalfardi;Farnia Mohammadifar;Arash Goodarzi;Ahmad Reza Farmani;Vahid Ramezani;Zahra Abpeikar. Exosome-based approaches in cancer along with unlocking new insights into regeneration of cancer-prone tissues.. Regenerative therapy(IF=3.5). 2025. PMID:40225049. DOI: 10.1016/j.reth.2025.03.005.
  • [7] Panagiotis Skouras;Antonios N Gargalionis;Christina Piperi. Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.. International journal of molecular sciences(IF=4.9). 2023. PMID:37373314. DOI: 10.3390/ijms241210162.
  • [8] Kishore Kumar Jella;Tahseen H Nasti;Zhentian Li;Sudarshan R Malla;Zachary S Buchwald;Mohammad K Khan. Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy.. Vaccines(IF=3.4). 2018. PMID:30261592. DOI: 10.3390/vaccines6040069.
  • [9] Chou-Yi Hsu;Abdulrahman T Ahmed;Pooja Bansal;Ahmed Hjazi;Hussein Riyadh Abdul Kareem Al-Hetty;Maytham T Qasim;Ibrokhim Sapaev;Mahamedha Deorari;Yasser Fakri Mustafa;Ahmed Elawady. MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells.. Journal of physiology and biochemistry(IF=4.3). 2024. PMID:39316240. DOI: 10.1007/s13105-024-01050-x.
  • [10] Shawna Benjamin-Davalos;Marina Koroleva;Cheryl L Allen;Marc S Ernstoff;Shin La Shu. Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies.. Frontiers in immunology(IF=5.9). 2021. PMID:33968029. DOI: 10.3389/fimmu.2021.638111.
  • [11] Chen Han;Cong Zhang;Hengxiao Wang;Lianmei Zhao. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment.. Oncoimmunology(IF=6.3). 2021. PMID:33680573. DOI: 10.1080/2162402X.2021.1887552.
  • [12] Ghader Babaei;Mehdi Asghari Vostakolaei;Masoumeh Rajabi Bazl;Shiva Gholizadeh-Ghaleh Aziz;Elham Gholipour;Kazem Nejati-Koshki. The role of exosomes in the molecular mechanisms of metastasis: Focusing on EMT and cancer stem cells.. Life sciences(IF=5.1). 2022. PMID:36270429. DOI: 10.1016/j.lfs.2022.121103.
  • [13] Lindsey T Brinton;Hillary S Sloane;Mark Kester;Kimberly A Kelly. Formation and role of exosomes in cancer.. Cellular and molecular life sciences : CMLS(IF=6.2). 2015. PMID:25336151. DOI: 10.1007/s00018-014-1764-3.
  • [14] Kun Liu;Xin Gao;Baoqiang Kang;Yunpeng Liu;Dingding Wang;Yi Wang. The Role of Tumor Stem Cell Exosomes in Cancer Invasion and Metastasis.. Frontiers in oncology(IF=3.3). 2022. PMID:35350566. DOI: 10.3389/fonc.2022.836548.
  • [15] Dandugudumula Ramu;Eunjoo Kim. Exosomal Lipids in Cancer Progression and Metastasis.. Cancer medicine(IF=3.1). 2025. PMID:40111100. DOI: 10.1002/cam4.70687.
  • [16] Miaowei Wu;Guosheng Wang;Weilei Hu;Yihan Yao;Xiao-Fang Yu. Emerging roles and therapeutic value of exosomes in cancer metastasis.. Molecular cancer(IF=33.9). 2019. PMID:30925925. DOI: 10.1186/s12943-019-0964-8.
  • [17] Meng Wang;Bo Zhang. The Immunomodulation Potential of Exosomes in Tumor Microenvironment.. Journal of immunology research(IF=3.6). 2021. PMID:34616851. DOI: 10.1155/2021/3710372.
  • [18] Ridwan Mahamed;Bernice Monchusi;Clement Penny;Sheefa Mirza. Cancer-derived exosomes: mediators of immune crosstalk and emerging targets for immunotherapy.. Frontiers in immunology(IF=5.9). 2025. PMID:41142789. DOI: 10.3389/fimmu.2025.1679934.
  • [19] Liliana Czernek;Markus Düchler. Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.. Archivum immunologiae et therapiae experimentalis(IF=3.9). 2017. PMID:28101591. DOI: 10.1007/s00005-016-0453-3.
  • [20] Wen-Jie Gu;Yi-Wen Shen;Li-Jun Zhang;Hong Zhang;Dale G Nagle;Xin Luan;San-Hong Liu. The multifaceted involvement of exosomes in tumor progression: Induction and inhibition.. MedComm(IF=10.7). 2021. PMID:34766148. DOI: 10.1002/mco2.49.
  • [21] Sang Bum Kim. Function and therapeutic development of exosomes for cancer therapy.. Archives of pharmacal research(IF=7.5). 2022. PMID:35604532. DOI: 10.1007/s12272-022-01387-1.
  • [22] Young Hwa Soung;Shane Ford;Vincent Zhang;Jun Chung. Exosomes in Cancer Diagnostics.. Cancers(IF=4.4). 2017. PMID:28085080. DOI: 10.3390/cancers9010008.
  • [23] Wei Guo;Yibo Gao;Ning Li;Fei Shao;Chunni Wang;Pan Wang;Zhenlin Yang;Renda Li;Jie He. Exosomes: New players in cancer (Review).. Oncology reports(IF=3.9). 2017. PMID:28627679. DOI: 10.3892/or.2017.5714.
  • [24] Jingjing Yu;Arsha Ostowari;Amber Gonda;Kiarash Mashayekhi;Farshid Dayyani;Christopher C W Hughes;Maheswari Senthil. Exosomes as a Source of Biomarkers for Gastrointestinal Cancers.. Cancers(IF=4.4). 2023. PMID:36831603. DOI: 10.3390/cancers15041263.
  • [25] Gilar Gorji-Bahri;Atieh Hashemi;Hamid Reza Moghimi. ExomiRs: A Novel Strategy in Cancer Diagnosis and Therapy.. Current gene therapy(IF=3.3). 2018. PMID:30332956. DOI: 10.2174/1566523218666181017163204.
  • [26] Yuju Zhou;Ying Zhang;Huan Gong;Siqi Luo;Yan Cui. The Role of Exosomes and Their Applications in Cancer.. International journal of molecular sciences(IF=4.9). 2021. PMID:34830085. DOI: 10.3390/ijms222212204.
  • [27] Man Li;Hongzhen Cai;Ruiyi Deng;Jin Cheng;Yanyan Shi. Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review).. International journal of oncology(IF=4.9). 2022. PMID:36222307. DOI: .
  • [28] Divya Mirgh;Swarup Sonar;Srestha Ghosh;Manab Deb Adhikari;Vetriselvan Subramaniyan;Sukhamoy Gorai;Krishnan Anand. Landscape of exosomes to modified exosomes: a state of the art in cancer therapy.. RSC advances(IF=4.6). 2024. PMID:39328877. DOI: 10.1039/d4ra04512b.
  • [29] Yating Wu;Yue Cao;Li Chen;Xiaofeng Lai;Shenghang Zhang;Shuiliang Wang. Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy.. Biological procedures online(IF=4.3). 2024. PMID:38802766. DOI: 10.1186/s12575-024-00245-2.
  • [30] Margherita Luongo;Pasqualina Laurenziello;Giuseppe Cesta;Anna Maria Bochicchio;Ludmila Carmen Omer;Geppino Falco;Maria Rita Milone;Francesca Cibarelli;Sabino Russi;Simona Laurino. The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor's biology and their translational prospects.. Molecular cancer(IF=33.9). 2024. PMID:39174949. DOI: 10.1186/s12943-024-02083-y.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Exosomes · Cancer Communication · Tumor Microenvironment · Biomarkers · Therapeutic Targets

© 2025 MaltSci